Analysis: 17 VC-backed Chinese companies that went public on Nasdaq and NYSE in the past 2 years have seen a ~91% average decline in their post-IPO stock price (Joanna Glasner/Crunchbase News)

Joanna Glasner / Crunchbase News:
Analysis: 14 self-driving vehicle tech companies that went public in the past two years have seen an 80%+ average decline in their post-IPO stock price  —  A few years ago, public market investors sometimes lamented the lack of opportunities to directly invest in future-shaping technologies like autonomous driving.

Joanna Glasner / Crunchbase News:
Autonomous trucking software company Embark lost ~98% of its market value, or ~$5B, since going public a year ago via a SPAC merger, amid a sector-wide downturn  —  Out of all the beaten-down public companies in the autonomous driving space, Embark Technology stands out as a conspicuously terrible stock market performer.

Bloomberg:
Since its NYSE debut in November 2013, Twitter stock has grown 8.4% annually on average, below the S&P 500’s 11% and Nasdaq 100’s 15%, due to slow user growth  —  Elon Musk’s buyout marks the end of nine years of public trading in Twitter Inc., which debuted with a bang but failed to match …

Frank Chaparro / The Block:
Sources: Nasdaq is exploring an institutional crypto custody service, pending regulatory approval, and a crypto-focused division called Nasdaq Digital Assets  —  – Nasdaq has been plotting a move into crypto custody, according to several sources.  — The move is in line with its broader mission …

Wall Street Journal:
Sources: Instacart plans to mostly sell employees’ stock during its IPO to help staff cash out, issuing a small number of shares and limiting the amount raised  —  Most shares listed will come from employees, in a move that could help the delivery company retain and recruit talent

Keerthi Vedantam / Crunchbase News:
Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+  —  This is not your average raise.  —  Biotech upstart Tempus announced on Thursday it raised $275 million through equity …